Only "Independent Expert’s preferred value of a ResApp share", these T/O are usually "premium" from a big pharma so....
- Forums
- ASX - By Stock
- RAP
- Ann: Pfizer raises scheme consideration to A$0.208 per share
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-3
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online